EUVIMEDEUVIMED entdecken
Crossref

Are Chinese Oncology Trials Generalizable to Non-Chinese Patients? A Call for Systematic Evidence

Auro del Giglio, Daniel Cubero

Clinical Oncology Letters · 2026 · 6 · e2026008

DOI: 10.4322/col.2026.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oncology Letters, 2026. Verfasst von Auro del Giglio und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Giglio, A. D., & Cubero, D. (2026). Are Chinese Oncology Trials Generalizable to Non-Chinese Patients? A Call for Systematic Evidence. Clinical Oncology Letters, 6, e2026008. https://doi.org/10.4322/col.2026.008

Vancouver

Giglio AD, Cubero D. Are Chinese Oncology Trials Generalizable to Non-Chinese Patients? A Call for Systematic Evidence. Clinical Oncology Letters. 2026;6:e2026008. doi:10.4322/col.2026.008

BibTeX
@article{Giglio2026,
  author = {Giglio, Auro del and Cubero, Daniel},
  title = {Are Chinese Oncology Trials Generalizable to Non-Chinese Patients? A Call for Systematic Evidence},
  journal = {Clinical Oncology Letters},
  year = {2026},
  volume = {6},
  pages = {e2026008},
  doi = {10.4322/col.2026.008}
}
Kostenlos starten →